Multiple lines of evidence indicate that NCC inhibition may contribute to hypomagnesemia by reducing the drive for apical Mg2+ entry through the inhibition of Na+-K+-ATPase [15,16]. The gene discussed is SLC12A3; the disease is familial primary hypomagnesemia.